Home
Conditions
Myelodysplastic-Myeloproliferative Diseases

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

154 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Not Yet Recruiting

Clonal Hematopoiesis of Immunological Significance

NCT05969821

Conditions: Autoimmune Diseases, Autoinflammatory Diseases, Blood Protein Disorders, +27 more
Locations: AP-HP, Service de médecine interne, Hôpital Saint Antoine Paris, France

View Trial Details

Completed

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

NCT02158858

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Disease, +23 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

UCLA Medical Center Los Angeles, California, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

Northwestern University - Lurie Comprehensive Cancer Center Chicago, Illinois, United States

View all 48 locations

View Trial Details

Completed

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

NCT03434730

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +23 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

NCT04902833

Conditions: Acute Myeloid Leukemia, Anemia, Anemia, Hemolytic, +24 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid Leukemia

NCT02257138

Conditions: Blasts More Than 20 Percent of Bone Marrow Nucleated Cells, Blasts More Than 20 Percent of Peripheral Blood White Cells, Bone Marrow Diseases, +11 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies

NCT00619879

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +27 more
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

NCT00611351

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
Locations: Unversity of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia

NCT01712308

Conditions: Anemia, Bone Marrow Diseases, Hematologic Diseases, +6 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

NCT00045305

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Mayo Clinic - Jacksonville Jacksonville, Florida, United States

Tufts-NEMC Cancer Center Boston, Massachusetts, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm

NCT04926194

Conditions: Allogeneic Hematopoietic Cell Transplant, Bone Marrow Diseases, Hematologic Diseases, +4 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Myelodysplastic-Myeloproliferative Diseases

Myelodysplastic-Myeloproliferative Diseases trial results

Related conditions